0

    523620

    PHRMASI

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    PHAARMASIA LTD. Share Price Today

    Investment Returns

    Over 1 Month 7.50% Over 3 Months 41.03% Over 6 Months -18.96% Over 1 Year 163.65%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    PHAARMASIA LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 68.50
    • P/E Ratio (TTM) 3.84
    • Beta 0.24
    • Book Value / share 26.14
    • Return on equity 0.00%
    • EPS (TTM) 2.89
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.70
    info icon alternate text

    PHAARMASIA LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 7.73
    Operating Expense 8.62
    Net Profit -0.70
    Net Profit Margin (%) -9.05
    Earnings Per Share (EPS) -1.03
    EBITDA -0.32
    Effective Tax Rate (%) -31.48
    Particulars DEC 2025 (Values in Cr)
    Revenue 16.05
    Operating Expense 15.29
    Net Profit 16.27
    Net Profit Margin (%) 101.37
    Earnings Per Share (EPS) 23.84
    EBITDA 20.00
    Effective Tax Rate (%) 18.27
    Particulars SEP 2025 (Values in Cr)
    Revenue 16.55
    Operating Expense 14.99
    Net Profit 1.74
    Net Profit Margin (%) 10.51
    Earnings Per Share (EPS) 2.54
    EBITDA 1.75
    Effective Tax Rate (%) -2.35
    Particulars JUN 2025 (Values in Cr)
    Revenue 6.87
    Operating Expense 6.88
    Net Profit 0.27
    Net Profit Margin (%) 3.93
    Earnings Per Share (EPS) 0.40
    EBITDA 0.39
    Effective Tax Rate (%) 12.90
    Particulars MAR 2025 (Values in Cr)
    Revenue 5.43
    Operating Expense 6.13
    Net Profit -0.53
    Net Profit Margin (%) -9.76
    Earnings Per Share (EPS) -0.77
    EBITDA -0.43
    Effective Tax Rate (%) -1.96
    Particulars MAR 2026 (Values in Cr)
    Revenue 47.21
    Operating Expense 45.76
    Net Profit 17.57
    Net Profit Margin (%) 37.21
    Earnings Per Share (EPS) 25.74
    EBITDA 21.82
    Effective Tax Rate (%) 17.85
    Particulars MAR 2025 (Values in Cr)
    Revenue 24.37
    Operating Expense 26.72
    Net Profit -1.59
    Net Profit Margin (%) -6.52
    Earnings Per Share (EPS) -2.33
    EBITDA -1.26
    Effective Tax Rate (%) 0.62
    Particulars MAR 2024 (Values in Cr)
    Revenue 30.59
    Operating Expense 31.80
    Net Profit -0.52
    Net Profit Margin (%) -1.69
    Earnings Per Share (EPS) -0.76
    EBITDA -0.16
    Effective Tax Rate (%) 5.45
    Particulars MAR 2023 (Values in Cr)
    Revenue 27.49
    Operating Expense 29.43
    Net Profit -1.26
    Net Profit Margin (%) -4.58
    Earnings Per Share (EPS) -1.84
    EBITDA -1.02
    Effective Tax Rate (%) 11.88
    Particulars MAR 2022 (Values in Cr)
    Revenue 17.22
    Operating Expense 19.24
    Net Profit -1.55
    Net Profit Margin (%) -9.00
    Earnings Per Share (EPS) -2.27
    EBITDA -1.27
    Effective Tax Rate (%) 1.28
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 6.58
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.01
    EBITDA Margin -5.17
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 8.87
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.03
    EBITDA Margin -0.52
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 9.62
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.02
    EBITDA Margin -3.75
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 11.45
    ROE % -17.98
    ROCE % -17.75
    Total Debt to Total Equity 0.00
    EBITDA Margin -7.38
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 13.79
    ROE % 3.34
    ROCE % 5.02
    Total Debt to Total Equity 0.01
    EBITDA Margin 5.10
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.36
    Total Assets 21.56
    Total Liabilities 21.56
    Total Equity 8.73
    Share Outstanding 0
    Price to Book Ratio 4.45
    Return on Assets (%) -7.37
    Return on Capital (%) -18.19
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.63
    Total Assets 31.44
    Total Liabilities 31.44
    Total Equity 10.29
    Share Outstanding 0
    Price to Book Ratio 3.28
    Return on Assets (%) -1.64
    Return on Capital (%) -5.03
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.69
    Total Assets 28.42
    Total Liabilities 28.42
    Total Equity 10.80
    Share Outstanding 0
    Price to Book Ratio 2.43
    Return on Assets (%) -4.43
    Return on Capital (%) -11.64
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.21
    Total Assets 21.20
    Total Liabilities 21.20
    Total Equity 12.05
    Share Outstanding 0
    Price to Book Ratio 2.70
    Return on Assets (%) -7.29
    Return on Capital (%) -12.8
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.38
    Total Assets 21.91
    Total Liabilities 21.91
    Total Equity 13.65
    Share Outstanding 0
    Price to Book Ratio 1.80
    Return on Assets (%) 1.42
    Return on Capital (%) 2.28
    Particulars MAR 2025 (Values in Cr)
    Net Income -1.60
    Cash from Operations 0.00
    Cash from Investing -0.12
    Cash from Financing -0.14
    Net change in Cash -0.26
    Free Cash Flow 0.16
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.54
    Cash from Operations 0.10
    Cash from Investing 0.00
    Cash from Financing -0.16
    Net change in Cash -0.05
    Free Cash Flow 0.13
    Particulars MAR 2023 (Values in Cr)
    Net Income -1.43
    Cash from Operations 0.64
    Cash from Investing -0.01
    Cash from Financing -0.16
    Net change in Cash 0.47
    Free Cash Flow 0.67
    Particulars MAR 2022 (Values in Cr)
    Net Income -1.56
    Cash from Operations 0.00
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash -0.16
    Free Cash Flow 0.00
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.47
    Cash from Operations 0.49
    Cash from Investing 0.00
    Cash from Financing -0.02
    Net change in Cash 0.22
    Free Cash Flow 0.49
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.27 13.33 1.56 247.30 23.12 38.85
    BLISS GVS PHARMA LTD 488.65 39.28 4.34 5182.44 118.35 552.90
    CIPLA LTD 1471.25 31.22 3.45 118854.24 1165.55 1672.20
    FERMENTA BIOTECH LTD. 395.00 17.42 2.85 1162.52 256.40 401.20
    GLAXOSMITHKLINE PHARMA LT 2400.60 42.26 17.93 40667.61 2088.00 3356.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.27 22.57 4.15 247.30 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 531.30 23.81 4.14 1536.02 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8222.25 107.38 23.55 20555.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 488.65 52.83 4.48 5182.44 118.35 552.90

    PHAARMASIA LTD. shareholding pattern

    Holding
    26.42%
    73.51%
    0.05%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    PHAARMASIA LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    95.52 -3.73 redarrow
    red-green-graph indicator
    9 Bearish
    7 Bullish
    • 5 Days 99.00
    • 26 Days 97.00
    • 10 Days 0.00
    • 50 Days 95.20
    • 12 Days 98.80
    • 100 Days 91.50
    • 20 Days 97.80
    • 200 Days 80.90
    98.74 PIVOT
    First Support 98.74 First Resistance 98.74 Second Support 98.74 Second Resistance 98.74 Third Support 98.74 Third Resistance 98.74
    RSI 52.99 ADX 18.91 MACD 1.97 Williams % R -47.10 Commodity Channel Index (CCI) -32.44
    Date 2026-07-06 Week 214.00 Same Day 139.00 Month 724.00
    1 Year 0.25 3 Year 0.35
    Over 1 Month
    7.50% down
    Over 1 Year
    163.65% down
    Over 3 Months
    41.03% down
    Over 3 Years
    59.33% down
    Over 6 Months
    -18.96% down
    Over 5 Years
    23.19% down

    PHAARMASIA LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Phaarmasia Ltd?

    Answer Field

    Phaarmasia Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 95.52 as on Jul 10 2026 03:04 PM.

    What is the Market Cap of Phaarmasia Ltd Share?

    Answer Field

    The market cap of Phaarmasia Ltd for NSE ₹ 0.00 & for BSE ₹ 68.50 as on Jul 10 2026 03:04 PM.

    What is the 52 Week High and Low of Phaarmasia Ltd?

    Answer Field

    The 52 Week High and Low of Phaarmasia Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 131.75 and ₹ 26.00.

    What is 1 year return for Phaarmasia Ltd?

    Answer Field

    The 1 year returns on the stock has been 163.21%.

    What is the P/E Ratio of Phaarmasia Ltd Share?

    Answer Field

    As on Jul 10 2026 03:04 PM the price-to-earnings (PE) ratio for Phaarmasia Ltd share is 3.84.

    What is the PB ratio of Phaarmasia Ltd Share?

    Answer Field

    As on Jul 10 2026 03:04 PM, the price-to-book (PB) ratio for Phaarmasia Ltd share is 26.14.

    How to Buy Phaarmasia Ltd Share?

    Answer Field

    You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Phaarmasia Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Phaarmasia Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Phaarmasia Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |